University of California, Riverside

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of California, Riverside sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 2 currently recruiting 5 completed early-phase tilt top decile by trial count

University of California, Riverside: 10 sponsored US clinical trials, 2 recruiting.

University of California, Riverside sponsors 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Mental Wellbeing, with 1 trials.

Top-decile sponsor footprint

University of California, Riverside ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

10 total, page 1 of 1

RECRUITING NA

Community Health Worker Navigation to Support Mental Health

NCT07387146
RECRUITING NA

Digital Health Intervention for Children With ADHD

NCT06456372
ACTIVE NOT RECRUITING Early Phase 1

The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude

NCT07517068
NOT YET RECRUITING Phase 2

A1Cantus vs. Placebo

NCT07585630
NOT YET RECRUITING NA

Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults

NCT06337721
COMPLETED NA

The Genomic and Well-Being Impacts of an Extraverted Behavior Intervention

NCT07690605
COMPLETED

Comic Relief: Graphic Medicine as Care for Caregivers

NCT07207265
COMPLETED NA

Impact of a Preoperative Instructional Video on Patient Preparedness

NCT07364968
COMPLETED NA

"Grow Well: Addressing Childhood Obesity in Low-income Families"

NCT05885581
COMPLETED NA

Stress Free UCR: The Impact of 8 Weeks of Headspace on Stress in a Heterogeneous University Employee Cohort

NCT03695627

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Therapeutic Areas

Mental Wellbeing 1
ADHD 1

What is open in the University of California, Riverside pipeline

2 recruiting of 10 indexed (20% open); 5 completed (50%).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Mental Wellbeing (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of California, Riverside: open-pipeline peers nationwide

Peers matched on 10 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

University of California, Riverside sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4681012 0%10%20%30%40% Total trials Recruiting share University of California, RiversideAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsAcera SurgicalAlign TechnologyAltruBioAlvernia University
University of California, Riverside sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of California, Riverside sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of California, Riverside page

10 registered trials is a research-attention snapshot, not an endorsement of University of California, Riverside or any single study.

  • 2 of University of California, Riverside's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Mental Wellbeing is the condition University of California, Riverside studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Mental Wellbeing trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of California, Riverside pipeline card: 10 registered trials from official public datasets.Report a data error.